Case Study

Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial

November 18, 2024June 25th, 2025
Optimizing-Early-Stage-Oncology-A-Strategic-Approach-to-Dose-Escalation-and-Expansion-in-Phase-I-Trials1_featured

Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial

Discover how a U.S. biotech company partnered with TFS HealthScience to manage a Phase I oncology trial for a new treatment targeting advanced epithelial tumors. The collaboration covered regulatory consulting, site identification, clinical monitoring, and other services to optimize dose escalation and expansion phases. TFS’s expertise streamlined operations, ensuring efficiency and adherence to regulatory standards.

What You’ll Learn:

  • How a specialized study team handles seamless trial execution & complex procedures effectively
  • The importance of proactive site selection, including a backup site, for enrollment speed & risk reduction
  • How prompt data reviews & safety updates allow for timely recruitment & study completion
  • The impact of skillful management on slot allocation, patient tracking, & data cleaning

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology & Hematology Expertise

Sarcoma
Up to 1 in 3 sarcoma diagnoses change on second reviewArticle

Up to 1 in 3 sarcoma diagnoses change on second review

TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
The new endpoints reshaping oncology trial designWebinars

The new endpoints reshaping oncology trial design

The endpoint and eligibility shifts reshaping oncology trial design in 2026. Watch the full replay or download the slides.
RWD
Getting real-world evidence to the sponsor before the deadline, not afterCase Study

Getting real-world evidence to the sponsor before the deadline, not after

When a tight oncology RWE deadline moved forward by 10 days, TFS HealthScience restructured the team and delivered. Download the case study to find out how.